Literature DB >> 14629650

Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells.

Akihide Itoh1, Jun Nishihira, Hironi Makita, Kenji Miyamoto, Etsuro Yamaguchi, Masaharu Nishimura.   

Abstract

OBJECTIVE: Cytokines have been implicated in the pathophysiology of pulmonary hypertension. We sought to explore the possibility that prostacyclin is a link.
METHODOLOGY: We tested the effects of the cytokines interleukin-1beta (IL-1beta), tumour necrosis factor-alpha (TNF-alpha), and macrophage migration inhibitory factor (MIF) on arachidonic acid metabolism of pulmonary artery smooth muscle cells (PASMCs) with special regard to prostacyclin (PGI2) that protects against pulmonary hypertension. Cultured rat PASMCs were treated with IL-1beta, TNF-alpha, or MIF. Expression of prostacyclin synthase (PGIS) and cyclooxygenase-2 (COX-2) mRNAs, and PGI2 synthesis, were measured.
RESULTS: We found that PGIS mRNA expression was suppressed by high concentrations of TNF-alpha and MIF, while COX-2 mRNA was induced by all three cytokines tested. IL-1beta increased PGI2 production in a dose-dependent manner. TNF-alpha and MIF also increased PGI2 production, but to a far lesser degree at high concentrations. TNF-alpha paradoxically decreased PGI2 production at a low concentration.
CONCLUSIONS: These results suggest that TNF-alpha and MIF are potentially antagonistic to the action of PGI2 in rat PASMCs via down-regulation of PGIS mRNA. Simultaneous induction of COX-2 mRNA may further counteract the action of PGI2 by increasing the levels of eicosanoids other than PGI2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629650     DOI: 10.1046/j.1440-1843.2003.00491.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  15 in total

1.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

Review 2.  Inflammation in Pulmonary Arterial Hypertension.

Authors:  Timothy Klouda; Ke Yuan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.

Authors:  Hilary M DuBrock; Josanna M Rodriguez-Lopez; Barbara L LeVarge; Michael P Curry; Paul A VanderLaan; Zsuzsanna K Zsengeller; Elizabeth Pernicone; Ioana R Preston; Paul B Yu; Ivana Nikolic; Dihua Xu; Ravi I Thadhani; Richard N Channick; S Ananth Karumanchi
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

4.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

5.  The Levels of TNF-α, Tissue Factor, and Coagulation Function in Rats with Pulmonary Hypertension and the Intervention Effect of Sildenafil Encapsulated by Targeted Nanocarriers.

Authors:  Xuan Ma; Xue-E Wang; Lin-Xia Xie; Sha Lu; Cheng Jiang
Journal:  Comput Math Methods Med       Date:  2022-05-13       Impact factor: 2.809

6.  Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation.

Authors:  Emmanouil Mavrogiannis; Quint A J Hagdorn; Venetia Bazioti; Johannes M Douwes; Diederik E Van Der Feen; Silke U Oberdorf-Maass; Marit Westerterp; Rolf M F Berger
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

Review 7.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

8.  Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension.

Authors:  Andrew J Sweatt; Haley K Hedlin; Vidhya Balasubramanian; Andrew Hsi; Lisa K Blum; William H Robinson; Francois Haddad; Peter M Hickey; Robin Condliffe; Allan Lawrie; Mark R Nicolls; Marlene Rabinovitch; Purvesh Khatri; Roham T Zamanian
Journal:  Circ Res       Date:  2019-03-15       Impact factor: 17.367

Review 9.  Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension.

Authors:  Bo Zhang; Min Shen; Min Xu; Li-Li Liu; Ying Luo; Dun-Quan Xu; Yan-Xia Wang; Man-Ling Liu; Yi Liu; Hai-Ying Dong; Peng-Tao Zhao; Zhi-Chao Li
Journal:  Mediators Inflamm       Date:  2012-01-18       Impact factor: 4.711

10.  Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.

Authors:  Arnaud Bianchi; David Moulin; Sylvie Sebillaud; Meriem Koufany; Marie-Madeleine Galteau; Patrick Netter; Bernard Terlain; Jean-Yves Jouzeau
Journal:  Arthritis Res Ther       Date:  2005-09-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.